| Literature DB >> 29541264 |
Giuseppe Troiano1, Luigi Laino1, Marco Cicciù2, Gabriele Cervino2, Luca Fiorillo2, Cesare D'amico2, Khrystyna Zhurakivska1, Lorenzo Lo Muzio1.
Abstract
The aim of this systematic review and meta-analysis was to compare the clinical efficacy of two routes of dexamethasone administration in reducing the postoperative sequelae after third molar extraction. Electronic databases (PUBMED, SCOPUS and EBSCO library) were screened in order to find both randomized and non-randomized clinical trials that directly compare the submucosal intraoral or the intramuscular extraoral administration of dexamethasone. No restriction about year of publication was imposed. About 340 titles and abstracts were screened independently by two authors. Of these [340 titles], only 4 randomized clinical trials met the inclusion criteria and were included in the meta-analysis. No statistical differences in postoperative pain, swelling and trismus were recorded comparing the intraoral submucosal and the extraoral intramuscular injection of dexamethasone in an extra-oral site.Entities:
Keywords: Corticosteroids; Edema; Oral surgery; Postoperative pain; Third molar; Trismus; Wisdom tooth
Year: 2018 PMID: 29541264 PMCID: PMC5842398 DOI: 10.2174/1874210601812010181
Source DB: PubMed Journal: Open Dent J ISSN: 1874-2106
Characteristics of studies included in meta-analysis.
|
|
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | Submucosal | Intramuscolar | – | – | Submucosal | Intramuscolar | – | – | – |
| 2011 | 4 mg | 10 | 10 | 27 | Parallel (3 groups) | 10 | 10 | Class II and III A, B, C Pell and Gregory | Triangular mucoperiosteal | Amoxicillina 500 mg every 8 h and Tradamol Tablets 50 mg | |
| 2011 | 4 mg | 11 | 11 | 26,9 | Parallel (3 groups) | 11 | 11 | Class II and III B, C Pell and Gregory | Triangular mucoperiosteal | Amoxicillina 500 mg every 8 h and Tradamol Tablets 50 mg arequrequiredmg as required | |
| 2013 | 4 mg | 12 | 12 | 25,6 | Parallel (6 groups) | 12 | 12 | Class II and III A, B, C Pell and Gregory | Triangular mucoperiosteal | Amoxicillina 500 mg every 8h and Tradamol Tablets 50 mg requiredmg | |
| 2014 | 4 mg | 10 | 10 | 24,1 | Parallel (6 groups) | 10 | 10 | Class II position B Pell and Gregory | Modified ward's mucoperiosteal | Amoxicillina 500 mg every 8 h and Paracetamol 650 mg for 5 days | |
Data extracted for outcomes: pain, swelling and trismus.
|
|
|
|
|
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| – | TEST (Submucosal) | CONTROL (Intra-Muscolar) | TEST (Submucosal) | CONTROL (Intra-Muscolar) | TEST (Submucosal) | CONTROL (Intra-Muscolar) | |||||||||||||
| VAS 100mm | 2,8 ± 3,1 | 3,6 ± 3,1 | 1,5 ± 2,4 | 1,1 ± 2,1 | 0,2 ± 0,6 | 0,2 ± 0,6 | ||||||||||||||
| VAS 100mm | 2,8 ± 2,9 | 3,7 ± 2,9 | 1,5 ± 2,3 | 1,2 ± 2 | 0,2 ± 0,6 | 0,2 ± 0,6 | ||||||||||||||
| VAS 10 cm | 2,9 ± 2,7 | 3,2 ± 3 | 1,4 ± 2,3 | 1,1 ± 2 | 0,2 ± 0,6 | 0,2 ± 0,6 | ||||||||||||||
| VAS Ten points | 1,8 ± 0,7 | 1,6 ± 0,8 | 1,2 ± 0,9 | 1,2 ± 0,9 | 1,0 ± 0,9 | 0,6 ± 0,6 | ||||||||||||||
| – | TEST (Submucosal) | CONTROL (Intra-muscolar) | TEST (Submucosal) | CONTROL (Intra-muscolar) | TEST (Submucosal) | CONTROL (Intra-muscolar) | ||||||||||||||
| Tragus-midline Gonion-lateral canthus | 0,7 ± 0,6 | 0,6 ± 0,75 | 0,5 ± 0,6 | 0,3 ± 0,42 | 0,06 ± 0,2 | 0,05 ± 0,15 | ||||||||||||||
| Tragus-midline Gonion-lateral canthus | 0,7 ± 0,6 | 0,9 ± 1,1 | 0,5 ± 0,5 | 0,5 ± 0,6 | 0,06 ± 0,1 | 0,1 ± 0,2 | ||||||||||||||
| Tragus-midline Gonion-lateral canthus Tragus-canthus of the mouth | 1,5 ± 0,6 | 1,2 ± 1,1 | 1,2 ± 0,5 | 0,7 ± 0,6 | 0,1 ± 0,1 | 0,1 ± 0,2 | ||||||||||||||
| Tragus-menton | 3,6 ± 1,0 | 3,8 ± 1,6 | 3,0 ± 1,0 | 3,0 ± 1,3 | 0,3 ± 0,4 | 0,4 ± 0,5 | ||||||||||||||
| – | TEST (Submucosal) | CONTROL (Intra-muscolar) | TEST (Submucosal) | CONTROL (Intra-muscolar) | TEST (Submucosal) | CONTROL (Intra-muscolar) | ||||||||||||||
| Maximal mouth opening | 10,8 ± 9,4 | 14,5 ± 9,3 | 8,2 ± 8,8 | 10,4 ± 8,8 | 5,4 ± 7,9 | 5,1 ± 4,3 | ||||||||||||||
| Maximal mouth opening (difference post-pre) | 11 ± 9 | 14 ± 9 | 8,5 ± 8,4 | 10 ± 8,4 | 5,5 ± 7,5 | 4,8 ± 4,2 | ||||||||||||||
| Maximal mouth opening | 11,5 ± 9 | 14 ± 9 | 8,6 ± 8,4 | 10 ± 8,4 | 5,2 ± 7 | 4,8 ± 4,2 | ||||||||||||||
| Maximal mouth opening (difference post-pre) | 2,3 ± 1,2 | 1,9 ± 0,7 | 2,0 ± 1,25 | 1,9 ± 1,6 | 0,9 ± 1,1 | 0,9 ± 1,1 | ||||||||||||||
Results about risk of bias in the included studies.
| Study | Sequence Generation | Allocation Concealment | Blinding | Incomplete Outcomes Data | Selective Reporting Bias | Other Sources of Bias |
|---|---|---|---|---|---|---|
| Majid (2011) | YES | YES | NO | NO | NO | YES |
| Majid and Mahmood (2011) | YES | YES | NO | NO | NO | YES |
| Majid and Mahmood (2013) | YES | YES | NO | NO | NO | YES |
| Barghava (2014) | UNCLEAR | UNCLEAR | YES | NO | NO | NO |